# Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)

Study · id `cardio:ct-nct01422616` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01422616](<https://clinicaltrials.gov/study/NCT01422616>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01422616

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: High blood pressure; Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4587 participants.

## Technical summary

Registry record NCT01422616. Randomized; single masking; primary purpose treatment. Start 2012-03 (actual); primary completion 2018-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4587 participants (enrolled count; ClinicalTrials.gov record NCT01422616, source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)
- Started: 2012-03 (actual) (ClinicalTrials.gov record NCT01422616, source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)
- Primary completion: 2018-08 (actual) (ClinicalTrials.gov record NCT01422616, source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)
- Completion: 2018-08 (actual) (ClinicalTrials.gov record NCT01422616, source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT01422616, source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01422616-2021-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
- Acronym: ENCHANTED
- Condition: Ischemic Stroke
- Condition: High Blood Pressure
- Intervention (Drug): Low-dose rtPA
- Intervention (Drug): Standard-dose rtPA
- Intervention (Other): Intensive blood pressure (BP) lowering
- Intervention (Other): BP management policies
- Lead sponsor: The George Institute
- Lead sponsor class: OTHER
- Collaborator: National Health and Medical Research Council, Australia
- Collaborator class: OTHER
- Collaborator: The Stroke Association, United Kingdom
- Collaborator class: OTHER
- Collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Collaborator class: OTHER\_GOV
- Collaborator: Takeda
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The George Institute for Global Health (`core:george-institute`)
- Registry lists this organization as a collaborator: National Health and Medical Research Council, Australia (`cardio:org-national-health-and-medical-research-council-australia`)
- Registry lists this organization as a collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico (`cardio:org-conselho-nacional-de-desenvolvimento-cientifico-e-e18697`)
- Registry lists this organization as a collaborator: Takeda (`cardio:org-takeda`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke (`cardio:pubmed-27161018`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (`cardio:pubmed-30739745`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (`cardio:pubmed-31812956`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes (`cardio:pubmed-30760277`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial (`cardio:pubmed-33031175`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial (`cardio:pubmed-33536271`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study (`cardio:pubmed-33526633`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study (`cardio:pubmed-34702064`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target (`cardio:pubmed-34096413`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study (`cardio:pubmed-39258531`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED Study (`cardio:pubmed-39541551`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results (`cardio:pubmed-40177745`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Body Weight in Relation to the Effectiveness of Intravenous Alteplase in Acute Ischemic Stroke: The ENCHANTED Trial (`cardio:pubmed-42644244`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8e779d9f37fe3a559cfa3dda79c4cc1801065b2d9a5f97dbf64d466a7e6b987b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
